Table 1.

Data sources used for the development of the pathways.

Data source (abbreviation)	Description of selected data
Administration (ADM)	Patient episodic information, comorbidities, and clinical coding.
Histopathology (HIST)	Histopathology reports and extracted Gleason grades.
Radiology (RAD)	Radiological imaging limited by reports where the word prostate occurs.
Biochemistry (LAB)	PSA tests. However, other blood tests can be added.
Operating theater (OT)	Operating theater procedures and coding.
Radiotherapy (RT)	Radiotherapy treatments dates and number of sessions.
Cancer registry datasets (CR)	The cancer registry dataset includes some of the above data, which can be used for quality checking purposes, and additional data such as cause of death.